Save Money On Your Rx
- Genetic study of Lewy body dementia supports ties to Alzheimer's and Parkinson's diseaseson February 16, 2021 at 7:43 pm
Scientists found that five genes may play a critical role in determining whether a person will suffer from Lewy body dementia, a devastating disorder that riddles the brain with clumps of abnormal protein deposits called Lewy bodies. The results also supported the disorder's ties to Parkinson's and Alzheimer diseases.
- Function identified of 'mystery protein' that kills brain cells of people with Parkinson'son February 10, 2021 at 2:11 pm
Scientists have made a 'vital step' towards understanding the origins of Parkinson's Disease - the fastest growing neurological condition in the world. A study presents a compelling new evidence about what a key protein called alpha-synuclein actually does in neurons in the brain.
- Ultrasound in the treatment of brain diseaseson February 4, 2021 at 7:40 pm
Ultrasound is not only used as an imaging technique but targeted pulses of ultrasound can be used as a highly accurate treatment for a range of brain diseases. A review shows that the new treatments are already on the brink of broad clinical application.
- Eye tests predict Parkinson's-linked cognitive decline 18 months aheadon January 19, 2021 at 3:28 pm
Simple vision tests can predict which people with Parkinson's disease will develop cognitive impairment and possible dementia 18 months later, according to a new study. In a related study, the researchers also found that structural and functional connections of brain regions become decoupled throughout the entire brain in people with Parkinson's disease, particularly among people with vision problems.
- Increased risk of Parkinson's disease in patients with schizophreniaon January 15, 2021 at 4:03 pm
A new study shows that patients with a schizophrenia spectrum disorder have an increased risk of Parkinson's disease later in life. The increased risk may be due to alterations in the brain's dopamine system caused by dopamine receptor antagonists or neurobiological effects of schizophrenia.